Dengue is caused by virus is also known as break bone fever. Dengue is spread by numerous mosquito species of Aedes group. Dengue attacked mostly in tropical countries. Unfortunately dengue has also becomes dengue hemorrhagic fever, which leads bleed from under skin or nose. It can turn dengue shock disorder which causes substantial shock and bleed. There is no precise cure and no vaccine avail...

Background: Aedes aegypti is the main vector of the yellow fever and dengue virus. This mosquito has become the major indirect cause of morbidity and mortality of the human worldwide. Dengue virus activity has been reported recently in the western areas of Saudi Arabia. There is no vaccine for dengue virus until now, and the control of the disease depends on the control of the vector. Objectiv...

Background and Objective: Dengue fever has become a major public health problem in many world regions due to increased trade, travel, and problems controlling Aedes vectors. This policy brief aims to review, analyze, and present evidence-based policies for dengue prevention and control. Methods: The present research is a compilation of a policy brief in Iran, carried out in 3 stages according ...

BACKGROUND Dengue is a mosquito-borne infectious disease that constitutes a growing global threat with the habitat expansion of its vectors Aedes aegyti and A. albopictus and increasing urbanization. With no effective treatment and limited success of vector control, dengue vaccines constitute the best control measure for the foreseeable future. With four interacting dengue serotypes, the develo...

Monocytes appear to play an important role in dengue virus infection. They have been identified as cells that support dengue virus replication (1) . Dengue virus has been recovered from circulating mononuclear cells and lymphoid organs of dengue virus-infected humans and monkeys (2-4). Cell separation experiments showed that dengue virus replicates in monocyte fractions, but did not replicate i...

This study compared the serum levels of IL-6, TNFand IFN, in children under 1 year of age with and without dengue. Sera were collected from a total of 41 children living in the Department of Antioquia, Colombia (27 patients with dengue and 14 controls). The results showed higher cytokine levels in children with dengue than without dengue, with statistically significant differences for IL-6 and ...

BACKGROUND Dengue fever is a rapidly emerging infection throughout the tropics and subtropics with extensive public health burden. Adequate training of healthcare providers is crucial to reducing infection incidence through patient education and collaboration with public health authorities. We examined how public sector healthcare providers in a dengue-endemic region of Ecuador view and manage ...

RV144 was a community-based HIV vaccine efficacy trial conducted in HIV-uninfected adults in Thailand, where dengue virus continues to cause a large number of infections every year. We attempted to document the accuracy of clinically diagnosed dengue episodes reported as serious adverse events (SAEs) and adverse events (AEs) and examine whether dengue serology would support the clinical diagnos...

A dot enzyme immunoassay (DEIA) for the detection of antibodies to dengue virus was tested for use as a tool in the presumptive diagnosis of dengue fever and dengue haemorrhagic fever. Paired sera from the following groups of patients were tested using the DEIA and the haemagglutination inhibition (HI) test: those with primary dengue fever; those experiencing a second dengue infection; and febr...

We estimate the proportion of patients hospitalized for suspected dengue that tested positive for influenza virus in El Salvador during the 2012 influenza season. We tested specimens from 321 hospitalized patients: 198 patients with SARI and 123 patients with suspected dengue. Among 121 hospitalized suspected dengue (two co-infected excluded) patients, 28% tested positive for dengue and 19% pos...